Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04736589
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-02-03
First Post:
2021-01-31
Brief Title:
Inetetamab Plus Rapamycin and Chemotherapy for HER2 Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
Sponsor:
Organization:
Peking Union Medical College